Risk Factors for Poor Tolerance of Ureteral Double-J Stent

NCT06815107 | Recruiting

• 1 other identifier: PI2020_843_0029
• Study Type: interventional
• Target: 200
• Locations: 1 country
• Sites: 1

Brief Summary

The placement of a Ureteral Double-J Stent as an emergency treatment or preparation for endoscopy after Colic nephritis is very frequent. It is often poorly supported, most often by young patients. A rich symptomatology is related to the probe responsible for a limitation of activities that can have a strong socio-economic impact. The objective of this study is the identification of the predictive factors of poor tolerance.

Conditions

Tolerance; Ureteral Double-J Stent; Urinary Symptoms

Keywords

Ureteral Double-J Stent; tolerance; urinary symptom

Outcome Measures

Primary Outcomes (2)

• tolerance score of Ureteral Double-J Stent

  A tolerance score of Ureteral Double-J Stent will be established using the USSQ questionnaire allowing the comparison of the symptomatology with and after ablation of the stent

  day 15

• tolerance score of Ureteral Double-J Stent

  A tolerance score of Ureteral Double-J Stent will be established using the USSQ questionnaire allowing the comparison of the symptomatology with and after ablation of the stent

  3 months

Interventions

questionnary OTHER

On day 1 of an ureteral double J stenting, each participant will receive the first USSQ questionnaire, in the French validated version. This questionnaire will be completed at home, one week after the intervention and returned at the following consultation or hospitalization.

USSQ survey OTHER

if the stent is removed less than 6 months later, the second USSQ survey, in the French validated version will be given to the patient when removing the stent. This questionnaire will be completed at home one week after removal of the stent and return to the referent hospital. If the patient does not return the second questionnaire, our team may contact them by phone to complete it.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• patient over 18 years old
• patient who need Ureteral Double-J Stenting

You may not qualify if:

• patient under 18 years old,
• Iterative change,
• understanding disorder,
• inability to answer the questionnaire,
• refusal of the patient,
• long-term Ureteral Double-J Stenting (more than 6 month),
• active cancer.

Sponsors & Collaborators

• Centre Hospitalier Universitaire, Amiens: lead
• Centre Hospitalier d'Abbeville: collaborator
• centre hospitalier de Compiegne: collaborator
• University Hospital, Caen: collaborator

Study Sites (1)

CHU Amiens-Picardie

Amiens, 80054, France

RECRUITING

Central Study Contacts

Philippe De Sousa, MD

CONTACT

33+322455775; desousa.philippe@chu-amiens.fr

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 4, 2025
• First Posted: February 7, 2025
• Study Start: April 15, 2020
• Primary Completion: April 15, 2021
• Study Completion: April 1, 2026
• Last Updated: February 7, 2025

Record last verified: 2025-01

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)